|
|
|
|
|
|
CHONGQING DAXIN PHARMACEUTICAL Co., Ltd is a subsidiary of PKU Healthcare Corp. Ltd (Stock code on Shenzhen Stock Exchange: 000788) located in Chongqing, China. It is a manufacturing, R&D and export enterprise of biopharmaceutical and synthetic pharmaceutical active pharmaceutical ingredients (APIs) and pharmaceutical preparations in western China. Our company is also the key enterprise of Chinese pharmaceutical industry, national innovative pilot enterprise, key high and new tech enterprise of national Torch Program, the brand leader enterprise supported by Chongqing government. It is an influential Lovastatin and Sulfonamides manufacturing enterprise all over the world.
Our company boasts several large-scale pharmaceutical manufacturing bases, including a modernized pharmaceutical site in Chongqing Liangjiang New Area, which meets international cGMP standards. It has hundreds of APIs and preparations which span more than 20 categories, including antimicrobials, cardiovascular treatments, vitamins, anti-inflammatories, immunosuppressive products and plasma volume expanders.
We are one of the top pharmaceutical enterprises owning the most certifications in China.
All the products have been approved by GMP. |
|
|
| vancomycin HCl, Sirolimus, Daptomycin, vancomycin base, API, Pharmaceutical, Lovastatin, Tobramycin, vancomycin |
|
|
| Company : |
PKU Healthcare Corp. Ltd |
| Email: |
Contact us |
| URL: |
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
